摘要
卵圆孔未闭(PFO)发生率高,约1/4的成年人均存在PFO。随着4项经导管封堵PFO和药物治疗相对比的随机对照研究结果的相继发表,各国相继更新了PFO相关指南或共识。我国关于PFO治疗的推荐仍停留在2017年的"卵圆孔未闭预防性封堵术中国专家共识"上,鉴于PFO人群基数庞大,为规范PFO封堵术的临床应用,在借鉴国内外最新研究的基础上,结合我国具体情况,国内本领域专家形成了卵圆孔未闭相关卒中预防中国专家指南,以供参考。
The incidence of patent foramen ovale(PFO) is high, and PFO is present in approximately onequarter of adults. As the results of randomized controlled trials comparing transcatheter PFO closure and drug therapy have been updated, countries have successively updated PFO guidelines or consensus. China′s recommendation for PFO treatment only stays on the 2017 " Chinese expert consensus on preventive closure of patent foramen ovale". In view of the large population of PFO, in order to standardize the clinical application of PFO closure, we learnt from the latest research at domestic and abroad, combined with the specific situation of China, experts in this field have developed a Chinese expert guidelines for the prevention of patent foramen ovale-associated stroke for reference.
作者
张玉顺
蒋世良
朱鲜阳
ZHANG Yu-shun;JIANG Shi-liang;ZHU Xian-yang(National Quality Control Center for Congenital Heart Disease Interventions,Structural Heart Disease Professional Committee of China Association for Promotion of Health Science and Technology,100037,Beijing,China)
出处
《心脏杂志》
CAS
2021年第1期1-10,共10页
Chinese Heart Journal
关键词
卵圆孔未闭
封堵
卒中
patent foramen ovale
closure
stroke
